Catalyst Pharmaceuticals, Inc. (CPRX) Social Stream
CATALYST PHARMACEUTICALS INC (CPRX) Price Targets From Analysts
Use the tables below to see what analysts covering CATALYST PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-05 | 5 | $11 | $6.5 | $8.5 | $15.29 | -44.41% |
| 2021-11-11 | 5 | $12 | $7 | $9.6 | $15.29 | -37.21% |
| 2022-01-13 | 5 | $12 | $7 | $9.8 | $15.29 | -35.91% |
| 2022-03-18 | 5 | $12 | $8 | $11 | $15.29 | -28.06% |
| 2022-03-27 | 5 | $12 | $8.75 | $10.95 | $15.29 | -28.38% |
| 2022-05-12 | 5 | $12 | $9 | $11 | $15.29 | -28.06% |
| 2022-07-12 | 5 | $15 | $9 | $11.6 | $15.29 | -24.13% |
| 2022-08-11 | 5 | $18 | $10 | $15.8 | $15.29 | 3.34% |
| 2022-08-24 | 5 | $18 | $15.5 | $16.9 | $15.29 | 10.53% |
| 2022-11-14 | 5 | $18 | $15.5 | $17.3 | $15.29 | 13.15% |
| 2022-12-20 | 5 | $22 | $15.5 | $18.5 | $15.29 | 20.99% |
| 2022-12-21 | 5 | $24 | $15.5 | $19.9 | $15.29 | 30.15% |
| 2023-02-07 | 5 | $24 | $15.5 | $20.7 | $15.29 | 35.38% |
| 2023-03-20 | 5 | $24 | $15.5 | $20.9 | $15.29 | 36.69% |
| 2023-05-12 | 5 | $25 | $16.25 | $21.65 | $15.29 | 41.6% |
| 2023-06-14 | 5 | $25 | $15 | $21.4 | $15.29 | 39.96% |
| 2023-08-11 | 5 | $25 | $15 | $22.6 | $15.29 | 47.81% |
| 2023-10-18 | 5 | $27 | $15.5 | $23.1 | $15.29 | 51.08% |
| 2023-11-10 | 5 | $27 | $15.5 | $23.3 | $15.29 | 52.39% |
| 2023-12-21 | 5 | $30 | $24 | $26.2 | $15.29 | 71.35% |
The Trend in the Analyst Price Target
Over the past 33 months, CPRX's average price target has gone up $18.7.
CPRX reports an average of 59.2% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-07 | 5 | 24 | 15.5 | 20.70 | 16.21 | 27.7% |
| 2023-08-11 | 5 | 25 | 15.0 | 22.60 | 14.88 | 51.88% |
| 2023-10-26 | 5 | 27 | 15.5 | 23.30 | 13.44 | 73.36% |
| 2023-11-10 | 5 | 27 | 24.0 | 25.25 | 12.85 | 96.5% |
| 2023-11-10 | 4 | 27 | 15.5 | 23.30 | 12.85 | 81.32% |
CPRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 19 months, CPRX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, CATALYST PHARMACEUTICALS INC's number of analysts covering the stock is greater than 480.26% of them.
- CPRX has a greater average analyst price target than 524.92% of all US stocks.
- CATALYST PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 547.33% of Pharmaceutical Products stocks.
- In terms of how CATALYST PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -494.47% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CATALYST PHARMACEUTICALS INC are LXRX, ANIP, and SIGA.
View All Top Stocks by Price Target
Is CPRX a Buy, Hold or Sell? See the POWR Ratings now!